India gets first dengue vaccine as DCGI approves Takeda’s QDENGA
India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to Takeda Biopharmaceuticals India’s QDENGA, marking a significant milestone in the country’s efforts to combat one of its most widespread mosquito-borne diseases, it was announced on Monday. Disclaimer: We do not own any of the content, ideas, images, or text presented here. All rights belong to their respective owners. For more information and to view the original source, please visit the following link: Source link







